Representative Agreement

    RNS Number : 0514D
  Bluewater Bio International
  09 September 2008
   

    Bluewater Bio International

    enters into definitive agreement with Zero Waste Technology as exclusive representative for the Kingdoms of Bahrain, Jordan, Kuwait and
Saudi Arabia

    9 September 2008
    Bluewater Bio International ("Bluewater Bio" or the "Company"), the provider of an advanced wastewater treatment solution named HYBACS,
is pleased to announce that it has entered into an exclusive representative agreement with Zero Waste Technology W.L.L. ('Zero Waste'), for
the sale of its HYBACS wastewater treatment solution in the Kingdoms of Bahrain, Jordan, Kuwait and Saudi Arabia.
    Zero Waste is a regional leader in solid waste management and recycling in Bahrain, UAE, Saudi Arabia and Jordan. The agreement, which
is binding, is accompanied by a broader memorandum of understanding, in which Bluewater Bio and Zero Waste intend to establish a joint
venture company for operating in the gulf region in the near future.
    Zero Waste has large scale operations in conjunction with partners across the Middle East and, most recently in partnership with IuT of
Austria, has established a pioneering bio methanisation plant at Tuas, Singapore. Completed in March 2008, the plant deploys anaerobic
digestion to process up to 800 tonnes of organic waste per day. 
    Najib El Khouri, Managing Director of Zero Waste Technology said, "Our appointment as exclusive sales representative for the sale of
HYBACS in our region marks the cornerstone for Zero Waste's future wastewater business much in the same way our deal with IuT did for solid
waste. We believe that HYBACS's superior treatment quality and better economics will give Zero Waste a strong competitive advantage
throughout the region".
    Daniel Ishag, CEO of Bluewater Bio, commented, "This is an important deal for Bluewater Bio, delivering to us a footprint in the highly
attractive and growing Middle Eastern market with a strong and established partner in Zero Waste. The intended joint venture between
Bluewater Bio and Zero Waste will give us immediate representation on the ground". 

    Enquiries:

 Bluewater Bio International                     Tel: +44 (0) 20 7907 9820

 Daniel Ishag, CEO

 Citigate Dewe Rogerson (PR advisor)            Tel: +44 (0) 20 7638 9571

 Tom Baldock /Lindsay Noton 

 Strand Partners Limited (Nominated Adviser)    Tel: +44 (0) 20 7409 3494 

 James Harris/Angela Peace


    Notes to Editors 

    About Bluewater Bio 

    Bluewater Bio International designs and markets a highly innovative advanced biological solution to the treatment of wastewater, called
HYBACS. This system deploys a different biological approach to any internationally established wastewater treatment process. Through its
design and operation, HYBACS biologically selects a particular group of bacteria, Bacillus, with unusual natural properties which if
correctly stimulated exhibit higher biological reaction rates than other known naturally occurring bacteria. 

    The Company believes that HYBACS will be proven to be commercially superior to the majority of existing comparable treatment processes
worldwide, and is able to treat efficiently both municipal wastewater as well as a wide range of organic industrial wastewaters, including
highly concentrated livestock wastewater and the effluent from, among others, breweries, food processors, textile manufacturers, hospitals,
factories and residential developments.

    Bluewater Bio is looking to make sales of its HYBACS technology globally.

    Key benefits of the HYBACS system include: 

    HYBACS produces high quality treated wastewater, treating the biological waste in municipal wastewater down to 10 mg/L BOD (Biological
Oxygen Demand), and up to 99 per cent. treatment of the biological waste in concentrated wastewaters;

    HYBACS requires between five and 15 per cent. less capital expenditure than most widely installed comparable technologies to achieve
these performance qualities on a like-for-like basis;

    HYBACS requires between 22 and 30 per cent. less ongoing operating expenditure based on an overall lower energy consumption requirement
on a like-for-like basis;

    HYBACS is highly suited to plant retrofitting which makes HYBACS more suitable for various types of plant upgrading as compared to many
other advanced modern wastewater treatment processes. In applications where odour levels emanating from the plant may be an issue, the
HYBACS process removes offensive odour without the requirement for additional deodorisation facilities which involve additional capital and
operating expenditures; and

    HYBACS removes approximately twice the concentration of E. coli bacteria, compared to conventional technology which may result in
moderately reduced operating expenditure at sites where disinfection of the effluent is required.

    About Zero Waste Technology

    Zero Waste Technology is a leading regional company in the business of technology/services supply, development and operations of waste
management facilities projects. Zero Waste utilizes natural solutions to reduce the effects of waste on the environment and maximize
resource recovery back to the nature. With local government and private investor partners, Zero Waste aim to transform the Middle East and
North Africa from oil and gas desert kingdoms to Eco friendly green nature. Zero Waste has been involved in the development of many waste
treatment projects including the first Anerobic Digestion plant for municipal waste in the Middle East in 1999. Additional information is
available at www.zwaste.com

    For further information on Zero Waste Technology, please contact: 
    Nadera Abuali
    Asda'a Burson-Marsteller
    Tel: +973 17 213133 
    Fax: +973 17 213134
    Email: n.abuali@asdaa.com




This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
AGRSSSFEUSASEFU
Bluwater Bio (LSE:BWB)
過去株価チャート
から 5 2024 まで 6 2024